Schwippert B - Search Results

1

Platelet activation in diabetic cardiovascular autonomic neuropathy.

Rauch U, Ziegler D, Piolot R, Schwippert B, Benthake H, Schultheiss HP, Tschoepe D. Rauch U, et al. Among authors: schwippert b. Diabet Med. 1999 Oct;16(10):848-52. doi: 10.1046/j.1464-5491.1999.00160.x. Diabet Med. 1999. PMID: 10547212

2

Large platelets continue to circulate in an activated state after myocardial infarction.

Schultheiss HP, Tschoepe D, Esser J, Schwippert B, Roesen P, Nieuwenhuis HK, Schmidt-Soltau C, Strauer B. Schultheiss HP, et al. Among authors: schwippert b. Eur J Clin Invest. 1994 Apr;24(4):243-7. doi: 10.1111/j.1365-2362.1994.tb01081.x. Eur J Clin Invest. 1994. PMID: 7519556

3

Platelet membrane activation markers are predictive for increased risk of acute ischemic events after PTCA.

Tschoepe D, Schultheiss HP, Kolarov P, Schwippert B, Dannehl K, Nieuwenhuis HK, Kehrel B, Strauer B, Gries FA. Tschoepe D, et al. Among authors: schwippert b. Circulation. 1993 Jul;88(1):37-42. doi: 10.1161/01.cir.88.1.37. Circulation. 1993. PMID: 7686453

4

Platelet-leukocyte-cross-talk in diabetes mellitus.

Tschoepe D, Rauch U, Schwippert B. Tschoepe D, et al. Among authors: schwippert b. Horm Metab Res. 1997 Dec;29(12):631-5. doi: 10.1055/s-2007-979115. Horm Metab Res. 1997. PMID: 9497901 Review.

5

Flow-cytometric detection of surface membrane alterations and concomitant changes in the cytoskeletal actin status of activated platelets.

Tschoepe D, Spangenberg P, Esser J, Schwippert B, Kehrel B, Roesen P, Gries FA. Tschoepe D, et al. Among authors: schwippert b. Cytometry. 1990;11(5):652-6. doi: 10.1002/cyto.990110515. Cytometry. 1990. PMID: 1696196 Free article.

6

Large platelets circulate in an activated state in diabetes mellitus.

Tschoepe D, Roesen P, Esser J, Schwippert B, Nieuwenhuis HK, Kehrel B, Gries FA. Tschoepe D, et al. Among authors: schwippert b. Semin Thromb Hemost. 1991 Oct;17(4):433-8. doi: 10.1055/s-2007-1002650. Semin Thromb Hemost. 1991. PMID: 1803514

7

Exposure of adhesion molecules on activated platelets in patients with newly diagnosed IDDM is not normalized by near-normoglycemia.

Tschoepe D, Driesch E, Schwippert B, Nieuwenhuis HK, Gries FA. Tschoepe D, et al. Among authors: schwippert b. Diabetes. 1995 Aug;44(8):890-4. doi: 10.2337/diab.44.8.890. Diabetes. 1995. PMID: 7542611

8

Platelets in diabetes: the role in the hemostatic regulation in atherosclerosis.

Tschoepe D, Roesen P, Schwippert B, Gries FA. Tschoepe D, et al. Among authors: schwippert b. Semin Thromb Hemost. 1993;19(2):122-8. doi: 10.1055/s-2007-994015. Semin Thromb Hemost. 1993. PMID: 8356457 Review.

9

Activated platelets in subjects at increased risk of IDDM. DENIS Study Group. Deutsche Nikotinamid Interventionsstudie.

Tschoepe D, Driesch E, Schwippert B, Lampeter EF. Tschoepe D, et al. Among authors: schwippert b. Diabetologia. 1997 May;40(5):573-7. doi: 10.1007/s001250050717. Diabetologia. 1997. PMID: 9165226

10

Platelet activation in diabetic microangiopathy.

Rauch U, Schwippert B, Schultheiss HP, Tschoepe D. Rauch U, et al. Among authors: schwippert b. Platelets. 1998;9(3-4):237-40. doi: 10.1080/09537109876762. Platelets. 1998. PMID: 16793709

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

29 results

Search Page